{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:03:11Z","timestamp":1781701391519,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,8,6]],"date-time":"2016-08-06T00:00:00Z","timestamp":1470441600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11255-016-1387-8","type":"journal-article","created":{"date-parts":[[2016,8,6]],"date-time":"2016-08-06T05:16:59Z","timestamp":1470460619000},"page":"2029-2042","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-0675","authenticated-orcid":false,"given":"Mehmet","family":"Kanbay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalcin","family":"Solak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrie","family":"Siriopol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baris","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,6]]},"reference":[{"issue":"11","key":"1387_CR1","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","volume":"19","author":"DL Regidor","year":"2008","unstructured":"Regidor DL, Kovesdy CP, Mehrotra R, Rambod M, Jing J, McAllister CJ et al (2008) Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol 19(11):2193\u20132203","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1387_CR2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A et al (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359(6):584\u2013592","journal-title":"N Engl J Med"},{"issue":"6","key":"1387_CR3","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","volume":"26","author":"J Floege","year":"2011","unstructured":"Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A et al (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 26(6):1948\u20131955","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"1387_CR4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2215\/CJN.01370211","volume":"6","author":"TB Drueke","year":"2011","unstructured":"Drueke TB, Lafage-Proust MH (2011) Sclerostin: just one more player in renal bone disease? Clin J Am Soc Nephrol 6(4):700\u2013703","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"1387_CR5","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1002\/jbmr.479","volume":"26","author":"MS Ardawi","year":"2011","unstructured":"Ardawi MS, Al-Kadi HA, Rouzi AA, Qari MH (2011) Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res 26(12):2812\u20132822","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1387_CR6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jc.2013-2786","volume":"99","author":"D Cejka","year":"2014","unstructured":"Cejka D, Marculescu R, Kozakowski N, Plischke M, Reiter T, Gessl A et al (2014) Renal elimination of sclerostin increases with declining kidney function. J Clin Endocrinol Metab 99(1):248\u2013255","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1387_CR7","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2337\/dc12-1691","volume":"36","author":"S Morales-Santana","year":"2013","unstructured":"Morales-Santana S, Garcia-Fontana B, Garcia-Martin A, Rozas-Moreno P, Garcia-Salcedo JA, Reyes-Garcia R et al (2013) Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels. Diabetes Care 36(6):1667\u20131674","journal-title":"Diabetes Care"},{"issue":"8","key":"1387_CR8","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1210\/jc.2013-1521","volume":"98","author":"KJ Claes","year":"2013","unstructured":"Claes KJ, Viaene L, Heye S, Meijers B, d\u2019Haese P, Evenepoel P (2013) Sclerostin: another vascular calcification inhibitor? J Clin Endocrinol Metab 98(8):3221\u20133228","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1387_CR9","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/ki.2015.194","volume":"88","author":"AR Qureshi","year":"2015","unstructured":"Qureshi AR, Olauson H, Witasp A, Haarhaus M, Brandenburg V, Wernerson A et al (2015) Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification. Kidney Int 88(6):1356\u20131364","journal-title":"Kidney Int"},{"issue":"8","key":"1387_CR10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ndt\/gfv081","volume":"30","author":"M Morena","year":"2015","unstructured":"Morena M, Jaussent I, Dupuy AM, Bargnoux AS, Kuster N, Chenine L et al (2015) Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications. Nephrol Dial Transplant 30(8):1345\u20131356","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"1387_CR11","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00198-015-3127-9","volume":"26","author":"S Pelletier","year":"2015","unstructured":"Pelletier S, Confavreux CB, Haesebaert J, Guebre-Egziabher F, Bacchetta J, Carlier MC et al (2015) Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients? Osteoporos Int 26(8):2165\u20132174","journal-title":"Osteoporos Int"},{"issue":"2","key":"1387_CR12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00059-013-3992-y","volume":"40","author":"M Balci","year":"2015","unstructured":"Balci M, Kirkpantur A, Turkvatan A, Mandiroglu S, Ozturk E, Afsar B (2015) Sclerostin as a new key player in arteriovenous fistula calcification. Herz 40(2):289\u2013297","journal-title":"Herz"},{"issue":"1","key":"1387_CR13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nefro.2015.07.006","volume":"36","author":"A Kirkpantur","year":"2016","unstructured":"Kirkpantur A, Balci M, Turkvatan A, Afsar B (2016) Serum sclerostin levels, arteriovenous fistula calcification and 2-years all-cause mortality in prevalent hemodialysis patients. Nefrologia 36(1):24\u201332","journal-title":"Nefrologia"},{"issue":"1\u20132","key":"1387_CR14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000366449","volume":"128","author":"P Delanaye","year":"2014","unstructured":"Delanaye P, Krzesinski JM, Warling X, Moonen M, Smelten N, Medart L et al (2014) Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients. Nephron Clin Pract 128(1\u20132):127\u2013134","journal-title":"Nephron Clin Pract"},{"issue":"8","key":"1387_CR15","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/ndt\/gfv043","volume":"30","author":"CY Yang","year":"2015","unstructured":"Yang CY, Chang ZF, Chau YP, Chen A, Yang WC, Yang AH et al (2015) Circulating Wnt\/beta-catenin signalling inhibitors and uraemic vascular calcifications. Nephrol Dial Transplant 30(8):1356\u20131363","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"1387_CR16","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1210\/jc.2015-3056","volume":"100","author":"P Evenepoel","year":"2015","unstructured":"Evenepoel P, Goffin E, Meijers B, Kanaan N, Bammens B, Coche E et al (2015) Sclerostin serum levels and vascular calcification progression in prevalent renal transplant recipients. J Clin Endocrinol Metab 100(12):4669\u20134676","journal-title":"J Clin Endocrinol Metab"},{"key":"1387_CR17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2015.10.031","volume":"452","author":"YT Lee","year":"2016","unstructured":"Lee YT, Ng HY, Chiu TT, Li LC, Pei SN, Kuo WH et al (2016) Association of bone-derived biomarkers with vascular calcification in chronic hemodialysis patients. Clin Chim Acta 452:38\u201343","journal-title":"Clin Chim Acta"},{"key":"1387_CR18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2369-14-219","volume":"14","author":"VM Brandenburg","year":"2013","unstructured":"Brandenburg VM, Kramann R, Koos R, Kruger T, Schurgers L, Muhlenbruch G et al (2013) Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study. BMC Nephrol 14:219","journal-title":"BMC Nephrol"},{"key":"1387_CR19","unstructured":"Higgins JPT GSe. (2011) Handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]"},{"key":"1387_CR20","unstructured":"Review Manager (Rev Man) (2012) [Computer program]. Version 5.2. The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen"},{"issue":"3","key":"1387_CR21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000368502","volume":"40","author":"A Nowak","year":"2015","unstructured":"Nowak A, Artunc F, Serra AL, Pollock E, Krayenbuhl PA, Muller C et al (2015) Sclerostin quo vadis?\u2014is this a useful long-term mortality parameter in prevalent hemodialysis patients? Kidney Blood Press Res 40(3):266\u2013276","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"1387_CR22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/ndt\/gfu301","volume":"30","author":"C Drechsler","year":"2015","unstructured":"Drechsler C, Evenepoel P, Vervloet MG, Wanner C, Ketteler M, Marx N et al (2015) High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant 30(2):288\u2013293","journal-title":"Nephrol Dial Transplant"},{"key":"1387_CR23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1471-2369-15-190","volume":"15","author":"FL Goncalves","year":"2014","unstructured":"Goncalves FL, Elias RM, dos Reis LM, Graciolli FG, Zampieri FG, Oliveira RB et al (2014) Serum sclerostin is an independent predictor of mortality in hemodialysis patients. BMC Nephrol 15:190","journal-title":"BMC Nephrol"},{"issue":"12","key":"1387_CR24","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1093\/ndt\/gft039","volume":"28","author":"L Viaene","year":"2013","unstructured":"Viaene L, Behets GJ, Claes K, Meijers B, Blocki F, Brandenburg V et al (2013) Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis? Nephrol Dial Transplant 28(12):3024\u20133030","journal-title":"Nephrol Dial Transplant"},{"key":"1387_CR25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000443845","volume":"132","author":"G Jean","year":"2016","unstructured":"Jean G, Chazot C, Bresson E, Zaoui E, Cavalier E (2016) High serum sclerostin levels are associated with a better outcome in haemodialysis patients. Nephron 132:181\u2013190","journal-title":"Nephron"},{"issue":"10","key":"1387_CR26","doi-asserted-by":"crossref","first-page":"E1854","DOI":"10.1210\/jc.2014-2042","volume":"99","author":"M Kanbay","year":"2014","unstructured":"Kanbay M, Siriopol D, Saglam M, Kurt YG, Gok M, Cetinkaya H et al (2014) Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients. J Clin Endocrinol Metab 99(10):E1854\u2013E1861","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1387_CR27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nephro.2014.04.002","volume":"10","author":"L Desjardins","year":"2014","unstructured":"Desjardins L, Liabeuf S, Oliveira RB, Louvet L, Kamel S, Lemke HD et al (2014) Uremic toxicity and sclerostin in chronic kidney disease patients. Nephrol Ther 10(6):463\u2013470","journal-title":"Nephrol Ther"},{"issue":"5","key":"1387_CR28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s11255-015-0971-7","volume":"47","author":"RM Moyses","year":"2015","unstructured":"Moyses RM, Jamal SA, Graciolli FG, dos Reis LM, Elias RM (2015) Can we compare serum sclerostin results obtained with different assays in hemodialysis patients? Int Urol Nephrol 47(5):847\u2013850","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"1387_CR29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2011.04.024","volume":"58","author":"MJ Budoff","year":"2011","unstructured":"Budoff MJ, Rader DJ, Reilly MP, Mohler ER 3rd, Lash J, Yang W et al (2011) Relationship of estimated GFR and coronary artery calcification in the CRIC (chronic renal insufficiency cohort) study. Am J kidney Dis 58(4):519\u2013526","journal-title":"Am J kidney Dis"},{"issue":"12","key":"1387_CR30","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/jbmr.1994","volume":"28","author":"R Kramann","year":"2013","unstructured":"Kramann R, Kunter U, Brandenburg VM, Leisten I, Ehling J, Klinkhammer BM et al (2013) Osteogenesis of heterotopically transplanted mesenchymal stromal cells in rat models of chronic kidney disease. J Bone Miner Res 28(12):2523\u20132534","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1387_CR31","first-page":"317","volume":"22","author":"R Koos","year":"2013","unstructured":"Koos R, Brandenburg V, Mahnken AH, Schneider R, Dohmen G, Autschbach R et al (2013) Sclerostin as a potential novel biomarker for aortic valve calcification: an in vivo and ex vivo study. J Heart Valve Dis 22(3):317\u2013325","journal-title":"J Heart Valve Dis"},{"issue":"6","key":"1387_CR32","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.semnephrol.2014.09.008","volume":"34","author":"J Bover","year":"2014","unstructured":"Bover J, Urena P, Brandenburg V, Goldsmith D, Ruiz C, DaSilva I et al (2014) Adynamic bone disease: from bone to vessels in chronic kidney disease. Semin Nephrol 34(6):626\u2013640","journal-title":"Semin Nephrol"},{"issue":"10","key":"1387_CR33","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.metabol.2015.07.011","volume":"64","author":"P Makras","year":"2015","unstructured":"Makras P, Delaroudis S, Anastasilakis AD (2015) Novel therapies for osteoporosis. Metab Clin Exp 64(10):1199\u20131214","journal-title":"Metab Clin Exp"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-016-1387-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-016-1387-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-016-1387-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:07:31Z","timestamp":1498320451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-016-1387-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,6]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1387"],"URL":"https:\/\/doi.org\/10.1007\/s11255-016-1387-8","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,6]]}}}